Our Services
Medical Information
Helpful Resources
Published on: 8/18/2026
Bone softening disorders go beyond common osteoporosis and include osteomalacia, rickets in children, X-linked hypophosphatemia, hypophosphatasia, Paget's disease of bone, renal osteodystrophy, and fibrous dysplasia, each weakening bone through different problems with vitamin D, phosphate, calcium, or bone remodeling. Warning signs often overlap and can be subtle, such as deep bone pain, muscle weakness, waddling gait, bowed legs, dental problems, or fractures from minor injuries. Causes range from vitamin D deficiency and malabsorption to kidney disease, certain medications, and inherited genetic mutations, so testing and treatment differ significantly by condition. There are several important distinctions to consider, including who is at risk and which symptoms need urgent evaluation, so see below to understand more.
Because these disorders are frequently missed or mistaken for arthritis, fibromyalgia, or normal aging, a free, instant, online symptom check can help you organize your symptoms, see which conditions may match, and decide what to discuss with a clinician next.
Last reviewed for medical accuracy: 08/18/2026
Bone softening disease refers to a group of conditions in which bones lose density, strength or structure, increasing the risk of pain, deformity and fractures. While osteoporosis is well known, there are rarer disorders that may fly under the radar. Understanding these less common conditions can help you recognize unusual symptoms and seek appropriate care.
Healthy bones maintain strength through a balance of mineral deposition (mainly calcium and phosphate) and breakdown. When this balance is disrupted—by nutritional deficiencies, genetic mutations or hormonal problems—bones can become poorly mineralized, structurally weak or abnormally remodeled.
Key factors in bone health:
Below are some lesser‐known bone softening diseases, their causes, symptoms and treatment approaches.
A rare inherited disorder caused by mutations in the ALPL gene, leading to low activity of an enzyme called alkaline phosphatase. This enzyme is crucial for mineralizing bone and teeth.
A paraneoplastic syndrome in which small, often benign tumors secrete excess FGF23, causing phosphate loss through the kidneys and defective bone mineralization.
A genetic disorder caused by mutations in the PHEX gene, leading to excessive FGF23 activity. Unlike tumor-induced osteomalacia, XLH manifests in childhood and persists into adulthood.
Genetic defects affecting vitamin D metabolism (Type I: conversion to active form; Type II: receptor resistance).
A group of kidney disorders where the renal tubules fail to acidify urine, leading to chronic metabolic acidosis and bone demineralization.
A mosaic genetic disorder (mutations in GNAS gene) that causes normal bone to be replaced by fibrous tissue, weakening the structure.
A group of genetic disorders affecting collagen (COL1A1, COL1A2 genes), leading to bone fragility rather than true softening, but bones can deform under normal stress.
Watch for:
If you experience these symptoms, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker to help clarify possible causes.
Key treatment principles:
Bone softening diseases vary in severity. Contact a healthcare professional right away if you experience:
Always speak to a doctor about any symptoms that could be life threatening or seriously affect your quality of life.
Understanding these lesser-known bone softening diseases empowers you to recognize warning signs early and pursue the right tests and treatments. With timely diagnosis, targeted therapies and lifestyle adjustments, many people lead active, fulfilling lives despite a bone softening disease.
(References)
* Scott CR. The genetic tyrosinemias. Am J Med Genet C Semin Med Genet. 2006 May 15;142C(2):121-6. doi: 10.1002/ajmg.c.30092. PMID: 16602095.
* Bullmann C, Benker G, Rosien U, Delling G, Siggelkow H, Schulte HM. [Hypophosphatemic osteomalacia]. Med Klin (Munich). 2008 Sep 15;103(9):671-5. doi: 10.1007/s00063-008-1106-z. Epub 2008 Sep 24. PMID: 18813890.
* Linglart A, Biosse-Duplan M. Hypophosphatasia. Curr Osteoporos Rep. 2016 Jun;14(3):95-105. doi: 10.1007/s11914-016-0309-0. PMID: 27084188.
* Zarate YA, Steinraths M, Matthews A, Smith WE, Sun A, Wilson LC, Brain C, Allgove J, Jacobs B, Fish JL, Powell CM, Wasserman WW, van Karnebeek CD, Wakeling EL, Ma NS. Bone health and SATB2-associated syndrome. Clin Genet. 2018 Mar;93(3):588-594. doi: 10.1111/cge.13121. Epub 2017 Dec 27. PMID: 28787087.
* Ramos-Fuentes F, González-Meneses A, Ars E, Hernández-Jaras J. Genetic Diagnosis of Rare Diseases: Past and Present. Adv Ther. 2020 May;37(Suppl 2):29-37. doi: 10.1007/s12325-019-01176-1. Epub 2020 Mar 31. PMID: 32236876.
* Iatan I, Lee TC, McDonald EG. Tenofovir-induced osteomalacia with hypophosphataemia. BMJ Case Rep. 2021 May 24;14(5). doi: 10.1136/bcr-2020-240387. Epub 2021 May 24. PMID: 34031073; PMCID: PMC8149310.
* Ferreira CR, Carpenter TO, Braddock DT. ENPP1 in Blood and Bone: Skeletal and Soft Tissue Diseases Induced by ENPP1 Deficiency. Annu Rev Pathol. 2024 Jan 24;19:507-540. doi: 10.1146/annurev-pathmechdis-051222-121126. Epub 2023 Oct 23. PMID: 37871131; PMCID: PMC11062289.
* Zárate-Mondragón FE, Alcántara-García RI, Belmont-Martínez L, Consuelo-Sánchez A, Fernández-Hernández L, Flores-Calderón J, González-Ortiz B, Guillén-López S, Hernández-Chávez E, Hernández-Vez G, López-Mejía L, Ignorosa-Arellano KR, Medina-Vega FA, Reyes-Apodaca M, Yokoyama-Rebollar E, Vela-Amieva M. Consenso mexicano de tirosinemia tipo 1. Bol Med Hosp Infant Mex. 2024;81(Supl 1):1-13. doi: 10.24875/BMHIM.24000025. PMID: 39009030.
* Ramakrishanan A, Parekh A, Gayana S, Velusamy S, Sadhoo A. Tumour-induced osteomalacia. Natl Med J India. 2024 Sep-Oct;37(5):253-256. doi: 10.25259/NMJI_639_21. PMID: 39953866.
* Khan AA, Rush ET, Wakeford C, Staub D, Brandi ML. Key Learnings from Clinical Research and Real-World Evidence on Asfotase Alfa Effectiveness in Hypophosphatasia: 10 Years Post-Approval. Adv Ther. 2025 Sep;42(9):4270-4299. doi: 10.1007/s12325-025-03309-1. Epub 2025 Jul 25. PMID: 40715944; PMCID: PMC12394269.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.